Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24049085 | 0.92 | GRIN2C (0.48) | GRIN2CTP53 | |
| SCHEMBL26065092 | 0.81 | HHAT (0.48) | GRIN2CTP53 | |
| SCHEMBL24049370 | 0.73 | GRIN2C (0.50) | GRIN2CTP53 | |
| SCHEMBL26065097 | 0.69 | GRIN2C (0.51) | GRIN2C | |
| SCHEMBL26065075 | 0.67 | GRIN2C (0.61) | GRIN2C | |
| SCHEMBL26065071 | 0.66 | GRIN2C (0.57) | GRIN2C | |
| SCHEMBL26065115 | 0.64 | GRIN2C (0.49) | GRIN2CTP53 | |
| SCHEMBL24049105 | 0.61 | GRIN2C (0.61) | GRIN2C | |
| SCHEMBL26065132 | 0.60 | GRIN2C (0.64) | GRIN2C | |
| SCHEMBL4775918 | 0.59 | GPR119 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355593-A1 | N-methyl-D-aspartic Acid Receptor Modulators | UNIV EMORY (US) | 2023-11-09 | — | — | US | disclosed |
| US-11738008-B2 | N-methyl-D-aspartic acid receptor modulators | EMORY UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355593-A1 | N-methyl-D-aspartic Acid Receptor Modulators | GRIN1, GRIN2A, GRM1 | GRIN2C 9/4885TP53 3107/4885 |
| US-11738008-B2 | N-methyl-D-aspartic acid receptor modulators | GRIN1, GRIN2A, GRM1 | GRIN2C 8/4885TP53 3189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.